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Available online 2 March 2008Apoptosis is a highly regulated cellular suicide program crucial for metazoan development. Yeast counterparts
of central metazoan apoptotic regulators, such as metacaspase Yca1p, have been identiﬁed. In spite of the
importance of Yca1p in yeast apoptotic process, many other factors such as Aif1p, orthologs of EndoG, AMID
and cyclophilin D play important roles in caspase-independent apoptotic pathways. This review summarized
recent progress about studies of various intrinsic and extrinsic apoptotic stimuli that may induce yeast cell
death via caspase-independent apoptosis.
© 2008 Elsevier B.V. All rights reserved.Keywords:
Apoptosis
AIF1
EndoG
AMID
MPTP1. Introduction
Apoptosis has been ﬁrst recognized during vertebrate development
as part of a natural process to remove superﬂuous or used-up cells [1,2].
The term apoptosis was coined by Kerr et al. in 1970s, which was
deﬁned as an active, orderly cell death process involving membrane
blebbing, shrinkage of the cytoplasm and nucleus, and disintegration of
the cells into apoptotic bodies surroundedbyan intact cellmembrane; a
more chaotic way of dyingwas named as necrosis, which is violent and
characterized by cytoplasmic swelling, membrane rupturing and
organelle dissolution [3]. Worth noting is that with the recent
development of our knowledge about cell death, some kinds of cell
death cannot ﬁt the simple dichotomy-apoptosis or necrosis.
The introducing of an invertebrate model organism, Caenorhabdtis
elegans, resulted in the great discovery of an executor of apoptosis-
caspase [4], which belongs to a family of cytosolic cysteine proteases,
and upon activation, functions as a caspase cascade, cleaving crucial
death substrates after Asp residues [5]. Largely dependent on in vitro
systems, the biochemical pathways of caspase activation during
apoptosis were elucidated [6]. However, numerous clues indicate
that the process of caspase activation is not the sole determinant of life
and death decisions in programmed cell death-PCD [7], and later Xiang
et al. clearly demonstrated a caspase-independent cell death [8]. Now,
accumulating pieces of evidence show that apoptosis-inducing factorhou).
tional Institute of Diabetes and
lth, Bethesda, Maryland 20892,
l rights reserved.(AIF) [9], AIF-homologous mitochondrion-associated inducer of death
(AMID) [10] and endonuclease G (EndoG) [11,12] can all induce
apoptotic cell death in a caspase-independentmanner. Comparedwith
caspase-dependent apoptotic cell death, our knowledge about the
mechanism of caspase-independent cell death is still at a very initial
stage.
For a long time, it has been imagined that apoptosis was limited to
multicellular organisms only, and thought there was no apoptotic
machinery in yeast. This idea was challenged by the discovery of an
apoptotic phenotype in a yeast strain carrying a CDC48mutation [13].
Like mammalian cells, yeast cells (Saccharomyces cerevisiae) under-
going apoptosis display characteristic markers such as DNA cleavage,
apoptosis-typical chromatin condensation, externalization of phos-
phatidylserine, and cytochrome c release from mitochondria [13–15].
The past 10 years have seen the discovery of several yeast orthologs of
crucial apoptotic regulators [16–28]. These ﬁndings ﬁrmly established
that yeast and metazoan apoptosis are in essence the same cellular
program and lay the foundation of using yeast as a tool for apoptosis
research. In this review we will summarize the recent progress on
caspase-independent apoptosis in yeast. Unless otherwise speciﬁed,
yeast as described in this review is meant to be S. cerevisiae.
2. Caspase-independent yeast death induced by heterologous
expression of proapoptotic genes
In the early studies of yeast death, yeast had long been assumed to
lack apoptotic processes, and therefore contain no apoptotic machin-
ery components such as caspase or Bcl-2 family members [29,30]. To
overcome the difﬁculty of elucidating the components and pathways
that are often interwoven with each other in mammalian cells, some
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lian elements in the budding yeast [29,31,32]. So yeast has been (and
still often is) employed as “clean room” for investigating the inter-
action of proteins involved in apoptosis and PCD in general [33].
Ced-3, Ced-4, and Ced-9 are key components of a cell suicide
program in C. elegans. Ced-4 facilitates the proteolytic activation of the
caspase, Ced-3, while Ced-9 opposes Ced-3/Ced-4 killing. One
interesting example is that without caspase Ced-3, Ced-4 was by itself
lethal when expressed in S. cerevisiae, revealing an intrinsic killing
activity of Ced-4 to yeast. Furthermore, only Ced-3 but not Ced-4
toxicity was attenuated by coexpression of caspase inhibitor CrmA, an
inhibitor of caspases derived from cowpox virus, and p35. Thus,
besides its Ced-3- and Ced-9-dependent action in C. elegans, it seemed
that Ced-4 has an additional caspase-independent killing mechanism
in yeast. It has been reported that the cell killing effect of Ced-4may be
mediated by its homomerization [34].
Heterologous expression of the human key apoptotic inducer Bax or
Bak is lethal for yeast [29,35]. This lethality can be suppressed by
coexpression of Bcl-2 family members such as Bcl-xL, Bcl-2, Mcl-1, and
A1, which are anti-apoptotic in vertebrates [29], suggesting Bax/Bak
induces yeast death by an apoptotic way. Indeed, Manon et al. [14]
demonstrated that Baxexpression resulted in the release of cytochrome
c frommitochondria— a hallmark of mammalian cell apoptosis [6]; Ink
et al. [39] showed that Bax or Bak expression in S. pombe induced
chromatin condensation and DNA cleavage; Ligr et al. [40] and Madeo
et al. [41] ﬁnally conﬁrmed the apoptotic features of Bax-expressing
yeast by TUNEL assay, Annexin V staining, detection of oxygen radical
generation and chromatin condensation. This kind of yeast killing effect
is not rescued by CrmA, implying that this apoptosis is caspase-
independent [36]. Recently, newevidence [37,38] further indicated that
yeast metacaspase YCA1/MCA1 (Yor197w) is neither necessary nor
facilitates Bax killing inyeast as coexpressed inducible YCA1/MCA1with
Bax did not exasperate Bax toxicity; and Bax expression in a strain
mutant for YCA1 displayed the same level of killing effect. As for the
downstreammachinerywithin yeast in this system, some yeastmutant
strains exhibiting greatly-reduced sensitivity to killing by Bax have
been found, and most of them suggest mitochondrial involvement in
modulating Bax sensitivity in yeast [42–45]. Furthermore, Pavlov et al.
[46] discovered a novel high-conductance Bax-dependent channel in
mitochondria of yeast and mammals. This channel was named the
mitochondrial apoptosis-induced channel and is a candidate for the
outer membrane pore through which cytochrome c and possibly other
factors exit mitochondria during apoptosis. Although one mitochon-
drial receptor for Bax has been found to be TOM22, a core component of
the mitochondrial outer membrane protein translocation pore [47],
other pieces of evidence [48] are more consistent with the view, as
proposed by Saito et al. [49] and Kuwana et al. [50], that Bax forms
channels in the mitochondrial outer membrane independent of the
presence of endogenous mitochondrial proteins.
3. Environmental stress- or drug-induced caspase-independent
yeast apoptosis
Many environmental factors or drugs such as hyperosmotic stress,
elevated temperature, mating-type pheromone or amiodarone, low
doses of H2O2 or acetic acid, osmotin, SFK1, aspirin, HOCl, or merely
sugar itself (reviewed in [51,52]) have been reported to be stimuli for
yeast to commit cell death associated with typical hallmarks of
metazoan apoptosis. However, few of them address the issue of the
role of caspases on the process of apoptosis. And in special cases there
are even some contradictory reports.
3.1. High temperature
Qi et al. [53] reported that when treated with high temperature
(37 °C), dying cdc13-1 cells displayed some phenotypic markers ofapoptosis such as exposure of phosphatidylserine on the outer leaﬂet
of the plasma membrane, accumulation of reactive oxygen species
(ROS), and induction of caspase activity based on retention of the
caspase inhibitor FITC-VAD-fmk. The study, however, fell short of using
more apoptotic markers and did not investigate the role of yeast
caspase and ROS in the cell death. Soon after, Wysocki and Kron [54]
showed that cell death triggered by cdc13-1 is independent of caspase-
like proteases including yeast metacaspase Yca1p and reactive oxygen
species but related to cell cycle arrest per se. Further, Yca1p caspase
activity as assayed by cell binding of mammalian caspase inhibitors is
confounded by artifactual labeling of dead yeast cells, which non-
speciﬁcally bind ﬂuorochromes. Thus, the cell death in the cdc13-1
mutant may not be related to caspase activation. They inferred that
cdc13-1 cell death may arise as a result of loss of cell wall integrity in
oversized, large-budded cells or via an active process such as induction
of autolysis and/or autophagy rather than apoptosis. Nevertheless,
these claims need to be established through direct evidence.
Collectively, although the cdc13-1 cell death at 37 °C may not be
caspase-dependent, the type of death is not clariﬁed andmay not even
be typical apoptosis.
3.2. Acetic acid
It has been reported that S. cerevisiae commits to apoptosis upon
treatment with acetic acid [55,56], and Yca1p is indicated as an
executor of acetic acid-induced apoptosis in yeast [19]. Recently,
Guaragnella et al. [57] showed that yeast cells lacking metacaspase
YCA1 gene underwent the process of acetic acid-induced apoptosis
in a manner similar to normal cells but at a lower rate, and although
z-VAD-fmk partially inhibited caspase-like activity, it did not affect
acetic acid-induced apoptosis in yeast. They suggested that Yca1p
participates in acetic acid-induced apoptosis in a manner unrelated to
its putative caspase-like activity.
3.3. NaCl stress
Evidence has been presented that exposure of yeast to high salinity
induces apoptosis [58]. It has been observed that deletion of SOP1/
SRO7 gene together with its iso-gene SRO77 brings about increased
sensitivity to NaCl stress and a defective intracellular ion homeostasis
[59]. Wadskog et al. [60] observed a signiﬁcant increase of the
proportion of wild-type cells with active caspase after exposure to
NaCl stress for 4 h, and signiﬁcantly improved survival rate at high
salinity when YCA1 is deleted, suggesting a general role for Yca1p in
salt-induced apoptosis. However, when treated with 1.2 M salt stress,
the observed caspase activity remained unaffected in sro77Δmutants,
similar to what was noted for yca1Δ cells, whereas sro7Δ yeast
exhibited a generally increased caspase activity than that of wild-type
cells. This ﬁnding, together with the observation that sro77Δ and
sro77Δ yca1Δ mutants exhibit NaCl-induced nuclear fragmentation
and strong DNA strand breakage, suggests the existence of a caspase-
independent apoptotic pathway in yeast when stressed with high salt.
It is clear now that the salt-sensitive phenotype of the yeast sro7Δ
mutant results from the defective targeting of ENA1 encoded sodium
extruding ATPase to the plasmamembrane [61]. But themechanism of
caspase-independent apoptosis as observed in sro77Δ mutants when
stressed with high salt is not yet clariﬁed.
3.4. Cu stress
Recently, Liang and Zhou [28] systematically compared the effect of
Cu and Mn stress, side by side, on yeast apoptosis. They demonstrated
that at sub-toxic levels both of them are beneﬁcial to yeast cells; at
moderate toxic levels, both metals induce extensive apoptosis in yeast
cells. While at even higher concentration, necrosis then takes over.
Mitochondria-defective yeast exhibited much reduced apoptotic
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indicating that mitochondria are involved in both Cu- and Mn-induced
apoptosis. ROSwere generated greatly in Cu- but not inMn-induced cell
death, and Cu toxicity could be alleviated by overexpression of SOD2
(Fig. 1), suggesting that ROS mediate Cu but not Mn toxicity. Yeast
metacaspase has different roles in Cu and Mn-induced apoptosis.
Deletion of YCA1 did not promote survival of wild-type cells exposed to
Cu2+. The results suggest that yeast metacaspase Yca1p may not be
involved in Cu-induced programmed cell death. In contrast to the Cu2+
ﬁndings, yca1Δ strain manifested better survival thanwild-type strains
after Mn2+ treatment, indicating that Yca1p is involved in Mn-induced
apoptosis. In summary, yeastmetacaspase is not involved in Cu-induced
apoptosis although it plays an important role in Mn-induced process.
3.5. Sphingolipid
Sphingolipid metabolism is suggested to play an important role in
apoptosis. Recently, it has been reported that two major sphingolipid
bases of fungi, dihydrosphingosine (DHS) and phytosphingosine
(PHS), have potent fungicidal activity with remarkably high structural
and stereochemical speciﬁcity against Aspergillus nidulans. Apoptotic
activity of DHS and PHS was revealed by induction of rapid DNA
condensation independent of mitosis, large-scale DNA fragmentation,
and exposure of phosphatidylserine in A. nidulans. A metacaspase
gene from A. nidulans, designated casA, has been cloned based on
sequence homology to Yca1p (YOR197w). Overexpression of casA
inhibited A. nidulans growth and caused morphological changes in a
manner consistent with apoptosis. casA gene appears not essential in
PHS-induced apoptosis, as PHS treatment of casAΔ cells induced rapid
DNA condensation and subsequent DNA fragmentation just as inwild-
type cells with similar kinetics [62]. Although absent further caspase
activity analysis, based on the ﬁnding that an evolutionarily conserved
caspase-independent apoptosis has been observed in mammalianFig.1. Caspase-independent pathways in yeast apoptosis. Several representative types of extr
lines indicate that the intermediate process is not clariﬁed at present. The two arrows from
Cpr3p, that are known to be involved in Cu2+-induced apoptosis. The two arrows (solid line a
in H2O2-induced apoptosis. The relationship between the two arrows, as shown in Cu2+ or H
necessarily represent separate pathways. cytochrome c release has been reported in acet
including even Yca1p, is still unclear. Metacaspase Yca1p, which is not included in this drawsystems and D. discoideum [63–66], it is likely that PHS-induced
apoptosis in A. nidulans is also caspase-independent.
3.6. Dermaseptin S3(1-16)
The dermaseptins are a family of cationic, lysine-rich, amphipathic
antimicrobial peptides from the tree-frog Phyllomedusa sauvagii [67].
Using S. cerevisiae as a model fungus, Morton et al. [68] showed that
the antifungal action of dermaseptin S3(1-16) [67] is due to the
induction of programmed cell death. Exposure to dermaseptin S3(1-
16) induced the production of reactive oxygen species; in the presence
of DsS3(1-16), the proportion of TUNEL-positive nuclei jumped from
approximately 1% for untreated to approximately 30%, and exposure
of phosphatidylserine at the cell surface also signiﬁcantly increased.
However, deletion of YCA1 did not confer any enhanced resistance to
DsS3(1-16)-induced killing. Consistent with this observation, there
was no DsS3(1-16)-induced activation of yeast caspase activity. In
contrast, Aif1p (see below) was shown to participate in dermaseptin
S3(1-16)-induced apoptosis [68]. Altogether, these pieces of evidence
indicate that exposure to DsS3(1-16) induces caspase-independent
apoptosis in yeast.
4. Endogenous caspase-independent pathways
External apoptotic factors exert their effects though intrinsic apo-
ptosis pathways. Progress has beenmade in the past years in identifying
yeast endogenous factors that contribute to caspase-dependent and
-independent apoptosis. Initially, the absence of orthologs of classical
mammalian apoptosis regulators appeared to challenge a common
mechanismof yeast andmammalian apoptosis. This ambiguitywas ﬁrst
solved with the discovery of the caspase ortholog Yca1p in yeast [19],
followed by reports for a series of endogenous proapoptotic factors such
as AIF [69], AMID [26] and EndoG [27].acellular stimuli-induced apoptosis via Yca1p-independent pathways are shown. Broken
Cu2+ represent respectively two components, ETC (electron transportation chain) and
nd broken line) from H2O2 indicate that Nuc1p and phosphorylation of H2B are involved
2O2-induced apoptosis here, is not known and the two arrows from each inducer do not
ic acid-induced apoptosis in yeast, but how cytochrome c relates to other pathways,
ing, is also involved in acetic acid, high salt and H2O2-induced apoptosis.
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Apoptosis-inducing factor (AIF) is a mitochondrial ﬂavoprotein
with NADH oxidase activity. It was originally discovered as a soluble
factor derived from permeabilized mitochondria of mammalian cells
that could translocate to isolated nuclei in cell-free systems and
induce some features of apoptosis such as chromatin condensation
and DNA fragmentation without the inter-nucleosomal cleavages that
give rise to DNA ‘laddering’ [65]. Cloning of the full length cDNAs
corresponding to mouse AIF (612 amino acids) and human AIF (613
amino acid) [65] revealed that AIF is strongly conserved between the
two mammalian species (92% a.a. identity for the whole protein) and
bears a highly signiﬁcant homology with oxidoreductases from all
eukaryotic and prokaryotic kingdoms in its C-terminal portion.
Microinjection of recombinant AIF into the cytoplasm of live cells
induced several hallmarks of apoptosis: nuclear chromatin condensa-
tion and DNA loss, dissipation of the ΔΨm, and exposure of
phosphatidylserine on the outer leaﬂet of the plasma membrane
[65]. None of these AIF effects can be prevented by the broad spectrum
caspase inhibitor z-VAD-fmk, indicating that they are caspase-
independent [65]. AIF has been regarded as the key to the conserved
caspase-independent pathways of cell death [9]. Similar to mamma-
lian AIF, yeast AIF homologue Ynr074cp also controls yeast apoptosis.
In an AIF1 knockout yeast strain H2O2- or acetate-induced apoptosis
was abolished and age-induced apoptosis was delayed; exposure of
Aif1p overexpressing cells to low doses of H2O2 resulted in massive
cell death after 20 h compared with H2O2-treated isogenic controls.
Chromatin condensation indicated by DAPI staining was detectable in
30% of Aif1p-overexpressing cells treated with H2O2, and over-
expression of Aif1p leads to DNA fragmentation in 80% of the cells,
as revealed by TUNEL staining [69]. The enhanced resistance to
oxidative stress of AIF1-disrupted cells appears opposite to the
situation in mammals, where loss of AIF renders many cell types
less able to deal with oxidative stress [70–73].
Mammalian AIF has been reported either to reside as a soluble
protein in the inter-membrane space [65], or to span the inner
mitochondrial membrane with the great majority of the protein in the
inter-membrane space [74,75]. Consistently, mitochondrial localiza-
tion for yeast Aif1p was demonstrated by cell fractionation and ﬂuo-
rescence microscopy, and further conﬁrmed by in vitro importing
experiments using a 35S-labeled Aif1p precursor, to be attached to the
inner mitochondrial membrane or alternatively, located in the matrix
[69].
Inhealthycells, AIF is conﬁned tomitochondriawhere it exerts avital
function in bioenergetic and redox metabolism [71,76–78]. Upon
induction by a variety of apoptotic agents, both recombinant and
endogenous AIF are released from mitochondria into the cytoplasm
[79,80]. In contrast to cytochrome c (which stays cytosolic), AIF moves
to the nucleus concomitant to the initial phase of chromatin condensa-
tion. A two-step process is required to release AIF: ﬁrst, a protease
cleaves AIF near amino acid 100, releasing it from the inner membrane;
second, AIF is released through the outer mitochondrial membrane by
the permeabilization of mitochondrial outer membrane [75]. Several
distinct cysteine proteases can, whereas caspases cannot, cleave AIF
between amino acids 102 and 103, in a process that may involve
proteolysis by m-calpain and/or one or more cathepsin proteases
[81,82]. Once in the cytoplasm, AIF appears to combine with one or
perhaps more factors, and translocates to the nucleus [65,77,83]. The
mode of action of S. cerevisiae Aif1p closely resembles that of mam-
malian AIF. Upon apoptosis induction by H2O2 or acetate, as well as in
chronologically aged cells, Aif1p translocates from the mitochondria to
the nucleus [69], where it can inﬂict nuclear DNA fragmentation and
chromatin condensation [84,85].
Mouse AIF displays a glutathione-reductase-like fold, with an FAD-
binding domain (a.a. 122–262 and 400–477), an NADH-binding
domain (263–399), and a C-terminal domain (478–610) with a longinsertion in a beta-hairpin loop, which may be related to its
apoptogenic functions [86]. Regardless of the presence or the absence
of NAD(P)H and/or FAD, AIF can induce nuclear apoptosis. Similarly,
the AIF-related protein AMID induces apoptosis even after deletion of
large parts of the protein that share homology with the ﬂavoprotein
domain of AIF [10,87]. These data strongly suggest that the
oxidoreductase activity of AIF can be dissociated from its apoptosis-
inducing function [74,88]. Humanmature AIF has a very similar crystal
structure, resembling that of oxidoreductases. Structure-based muta-
genesis shows that DNA-binding defective mutants of AIF fail to
induce cell death while retaining nuclear translocation [84]. Recom-
binant AIF can directly bind to DNA as well as to RNA. This interaction
with DNA is accompanied by DNA condensation (as indicated by
shortening of the DNA), hairpin formation (intramolecular packaging)
and DNA oligomerization. DNA binding and DNA condensation by AIF
require the presence of Mg2+. Among the preferred electron donors
and acceptors of AIF, nicotine adenine dinucleotide phosphate (NADP)
is particularly efﬁcient in enhancing the generation of higher-order
AIF/DNA and AIF/RNA complexes [89]. Similarly, puriﬁed recombinant
yeast Aif1p from E. coli exhibited a DNase activity on puriﬁed yeast
nuclei and plasmid DNA. This function is dose dependent, as well as
relying on the presence of divalent cations but not FAD, indicating that
the predicted FAD-binding domain and the NADH oxidoreductase
activity are not involved [69].
In addition, human cyclophilin A (CypA) can interact with AIF in
vivo and it has been demonstrated in vitro that a molecular complex
composed of AIF and CypA has DNase activity on puriﬁed DNA. AIF
mutants lacking the CypA-binding domain were shown to be
inefﬁcient apoptosis sensitizers in transfection experiments, and AIF
failed to sensitize CypA knockout cells to apoptosis induction [77].
Consistently, disruption of CPR1, the yeast homologue of human CypA,
but not the cyclophilin B homologue CPR2, abrogated cell death
induced by overexpression of Aif1p. Thus, CypA is essential for the
proapoptotic activity of AIF.
Although it still remains unclear whether or to what extent
nuclear AIF plays a role in these events in physiological apoptosis,
current data support a model in which a direct interaction of AIF
contributes to the compaction of nucleic acids within apoptotic cells.
AIF has been reported to be essential to survival in mammals. Knock
out of AIF in the mouse is lethal before birth; and AIF-negative
embryonic stem (ES) cells are relatively resistant to apoptosis
induced by serum deprivation compared to wild-type ES cells [64].
However, these embryonic stem cells are sensitive to cell death
induced by staurosporine, etoposide, azide, ter-butyl hydroperoxide,
anisomycin and UV [63]. It is difﬁcult to conﬁrm that the observed
phenotype of AIF KO mice is really dependent on a defect in the
apoptogenic function of AIF or other physiological functions of AIF.
Moreover, the Harlequin (Hq) mouse that expresses 20% or less of
normal levels of AIF exhibits increased degeneration of certain
neurons in adult animals, accompanied by evidence of oxidative
stress [71]. AIF deﬁciency compromises oxidative phosphorylation in
Hq mouse retinal and cerebellar neurons, as well as several other
types of cells [90]. Altogether, these observations suggest a novel,
non-apoptotic function for AIF: AIF may have a dual function that
can deal with events of life and death [80,91]. As has been pointed
out by Porter and Urnano [80], the pro-survival function of AIF plays
a crucial role in development and physiology, whereas the pro-cell
death activity of AIF might function only in certain stress-induced or
pathological cell deaths.
4.2. AMID
The AIF family has two additional members in humans — AIFL
(AIF-like) and AMID. Human AIFL induces apoptosis in a caspase-
dependent manner when heterologously expressed [92]. However,
AMID-induced apoptosis is not inhibited by the pan-caspase
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apoptosis is caspase-independent. AMID is a ﬂavoprotein, possessing
NAD(P)H oxidase activity, and catalyzes NAD(P)H-dependent reduc-
tion of cytochrome c and other electron acceptors, including
molecular oxygen. AMID, like AIF, has signiﬁcant homology with
NADH oxidoreductases/ﬂavoproteins from bacteria to mammalian
species. AMID binds 6-hydroxy-FAD to form a stoichiometric
cofactor_protein complex, and is a DNA-binding protein that lacks
apparent DNA sequence speciﬁcity [93]. Similar to AIFL, AMID lacks a
recognizable MLS (mitochondrial localization signal), but is asso-
ciated with the outer membrane of mitochondria and localized in
the cytosol. The association of AMID to the outer membrane of
mitochondria is critical for AMID-induced apoptosis [10]. It is clear
that transcription of human AMID gene is upregulated by p53 and
genotoxins [87,94]. Amid−/− embryonic ﬁbroblasts exhibit normal
proliferation but are partially resistant to genotoxin-induced growth
arrest [95]. The exact mechanism by which AMID induces apoptosis
is still unknown in mammalian cells, and requires further investiga-
tion. Recent yeast studies may have shed some light on this issue.
There are two closely related genes of human AMID in yeast: NDE1
and NDI1, which code for external NADH dehydrogenase and internal
NADH dehydrogenase, respectively [26]. Overexpression of yeast
AMID homologue internal NADH dehydrogenase (NDI1), but not
external NADH dehydrogenase (NDE1), can cause apoptosis-like cell
death, and this effect can be repressed by increased respiration on
glucose-limited media (0.1% glucose), on non-fermentable (e.g.
glycerol, ethanol) or on semi-fermentable media (e.g. rafﬁnose,
galactose). NDI1 overexpression in sod2Δ background causes cell
lethality in both fermentable and semi-fermentable media. Consis-
tently, disruption of NDE1 or NDI1 decreased ROS production and
prolonged the chronological life span of yeast, albeit with loss of
survival ﬁtness. So the apoptotic effect of NDI1 overexpression is
associated with increased ROS production, probably produced as a
by-product of the NADH dehydrogenase activity of Ndi1p, when
glucose is used as the energy source accompanied by a 5–10-fold
repression of intramitochondrial SOD2 activity [96]. In this process, it
seemed that ROS is an important mediator which damages the
mitochondria and further triggers mitochondrial membrane per-
meabilization, and ultimately leads to cell apoptotic death. Recently,
Ndi1p together with Qcr7p and Cox12p was demonstrated to be
involved in Cu- and Mn- induced yeast apoptosis; but aif1Δ strains
didn't signiﬁcantly improve the viability of yeast cells when
incubated with Cu2+ [28], suggesting that the role of Ndi1p in
apoptosis is largely different from that of Aif1p in yeast.
4.3. EndoG
Chromatin condensation and DNA fragmentation are both key
features of apoptosis, and caspase activated DNase (CAD) is the best
characterized endonuclease in charge of the caspase-dependent
apoptotic process [97]. An alternative endonuclease EndoG, involved
in caspase-independent apoptosis, is a mitochondrial enzyme origin-
ally proposed to participate in the replication of mitochondrial DNA
[98]. EndoG is activated by a change in its subcellular localization: in
normal cells it locates within the mitochondrial inter-membrane
space [99], and upon apoptosis induction, EndoG is released from the
mitochondrion into the cytosol where it further translocates to the
nucleus and generates oligonucleosomal DNA fragmentation. The
whole process occurs independent of caspase activation [11,100].
Genetic studies showed that an EndoG mutation results in less
effective DNA degradation and delays apoptosis in vivo [12]. However,
the pathway of EndoG-mediated death is largely unknown, and a lot of
conﬂicting viewpoints and controversial data about EndoG exist in
mammalian cell studies.
The in vivo role of EndoG in mammalian development and
apoptosis was investigated in EndoG deﬁciency cells and mice [101].This study demonstrated that EndoG homozygous mutation leads to
early embryo lethality. Cells from EndoG heterozygous mutant mice
exhibit increased resistance to both tumor necrosis factor α- and
staurosporine-induced cell death. Moreover, DNA fragmentation is
also reduced in EndoG+/− thymocytes and splenocytes compared with
wild-type cells on activation of apoptosis. Theseﬁndings indicated that
EndoG is essential during early embryogenesis and plays a critical role
in normal apoptosis and nuclear DNA fragmentation. But other studies
provided contrast evidence for the role of EndoG in embryogenesis and
apoptosis [102,103]. The later studies revealed that EndoG null mice
are viable and develop to adulthood with no obvious abnormalities,
and ﬁbroblasts generated from EndoG null mice show no difference in
susceptibility when induced to die by a variety of intrinsic or extrinsic
apoptotic stimuli. So the exact role and relevance of EndoG in embryo-
genesis and apoptosis remain controversial.
Recent yeast study has provided valuable insights into how EndoG
regulates life and death [27]. Yeast Nuc1p, which contains a potential
MLS, was found to be the homologue of mammalian EndoG based on
sequence comparison. Nuc1p is to date the best-conserved yeast
homologue of a mammalian apoptosis regulator. Overexpression of
yeast EndoG (Nuc1p) led to increased apoptosis compared with
control upon treatment with either acetic acid or H2O2, and this effect
depended on its nuclease activity and MLS as revealed through
mutational analysis. Similar to human EndoG, Nuc1p was found to be
predominantly localized to mitochondria, and upon treatment with
H2O2, Nuc1p became concentrated within the nuclei of yeast cells.
Nuc1p-mediated death is independent of yeast metacaspase Yca1p
and Aif1p. Interestingly, deletion of NUC1 inhibits apoptotic cell death
on glycerol (and at least partially on glucose) but strongly enhances
necrotic death on glucose, meaning that in the respiratory phase
Nuc1p acts as promoter of apoptosis while it protects from non-
apoptotic death when oxidative phosphorylation is suppressed.
Furthermore, in a biochemical effort to identify putative Nuc1p
interacting proteins, some components of mitochondrial permeability
transition pore (MPTP), histone H2B (see below), and a protein
involved in nuclear import named karyopherin (Kap123p) were co-
puriﬁed with FLAG-tagged Nuc1p. Overexpression of Nuc1p did not
result in additional cell death, and deletion of KAP123 signiﬁcantly
protected Nuc1p-mediated death at lower concentrations (0.2 mM) of
H2O2. In contrast, neither the deletion of karyopherin KAP114 nor that
of KAP120 inhibited Nuc1p-mediated death, suggesting a speciﬁc role
of KAP123 in this process. Using aging as a more physiological
stimulus for apoptosis, Nuc1p overexpression led to massive cell
killing in thewild-type, whereas death was completely inhibited upon
KAP123 disruption during early time points. In addition to that,
evidence was presented to show that Yca1p-mediated death is not
dependent on KAP123; deletion of AIF1 in the NUC1-deleted back-
ground provoked a dramatic additional decrease in viability. Thus,
NUC1 and AIF1 are in two independent pathways that can partially
compensate with each other. This was explained by that the nuclease
activities of AIF and EndoG may have overlapping functions, as both
enzymes show a relatively broad speciﬁcity for nucleic acids and a
mitochondrio-nuclear localization. This Nuc1p study suggests the
existence of a similar caspase-, and AIF-independent mechanism for
EndoG-mediated apoptosis in mammalian cells. And the requirement
for respiratory growth to detect attenuation of apoptotic responses in
nuc1Δ yeast cells predicts that in mammals, EndoG-dependent cell
death might be detected in quiescent, terminally differentiated cells,
which exhibit a higher rate of respiration, while in early development
or in rapidly dividing cells EndoGmight be involved in proliferation by
reducing non-apoptotic death.
4.4. Mitochondrial permeability transition pore
Increase ofmitochondrial membrane permeability is one of the key
events in apoptotic and necrotic death. The mitochondrial membrane
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mitochondrial membrane permeability that leads to loss of ΔΨm,
mitochondrial swelling, rupture of the outermitochondrialmembrane
and ﬁnally, the release of apoptotic mediators. The MPT is thought to
occur after the opening of a channel known as MPTP, which putatively
consists of the voltage-dependent anion channel (VDAC), the adenine
nucleotide translocator (ANT), cyclophilin D (Cyp D: a mitochondrial
peptidyl-prolyl cis–trans isomerase), and other molecule(s) [104,105].
Deletion of yeast AAC proteins protects cells from acetic acid and
diamide exposure. It has been shown that absence of AAC proteins
impairs mitochondria outer membrane permeabilization and release
of cytochrome c (16). Further, as mentioned above, the yeast
homologues of mammalian ANT (Aac2p) and VDAC (Por1p) were
found to be co-puriﬁed with yeast EndoG (Nuc1p). The role of AAC
proteins in yeast apoptosis was ﬁnally established by that aac2Δ
signiﬁcantly reduced and a strain disrupted in all three isoforms of
AAC (Δaac1/2/3) completely abolished Nuc1p-facilitated killing [27].
In a separate study, a genetic screen to search for gene(s) that may be
involved in Cu-induced caspase-independent cell death cascade
identiﬁed yeast CPR3, a mammalian cyclophilin D homologue,
involved in Cu-induced apoptosis. The resistance of cpr3Δ cells to Cu
was comparable to that of petite cells, suggesting necrosis was
unaffected. These results clearly indicated that Cpr3p mediates the
apoptosis process induced by Cu in yeast [28].
4.5. Histone H2B
Although signiﬁcant progress has been made in identifying
networks of upstream apoptotic regulators and effectors (reviewed
in [106]), the molecular details of downstream events are relatively
less clear. Posttranslational histone modiﬁcations are very important
in a wide range of DNA-templated processes. In human, chicken, and
Xenopus cells, phosphorylation of H2B at serine 14 (S14) by Mst1
kinase, the mammalian sterile 20-like kinase, has been demonstrated
closely associated with apoptosis [107]. Ahn et al. [24,25] discovered
a crosstalk pathway between H2BS10 phosphorylation (H2BS10ph)
and lysine 11 acetylation (H2BK11ac) in yeast, which is independent
on caspase. Firstly, it was found that in budding yeast the amino
terminus of histone H2B, but not the N-terminal of any other core
histone, is associated with an apoptotic-like role. Then it was
revealed that the phosphorylation of S10 in H2B is essential for the
induction of the apoptotic-like cell death, and this process was
catalyzed by sterile 20 kinase (Ste20p). Phosphorylation of S10
appears to be inhibited by acetylation of histone H2B at K11, pointing
to a mutually exclusive existence of the K11ac and S10ph marks in
the tail of H2B. Upon induction by H2O2, the acetyl mark on K11 is
removed by the HDAC Hos3, and at the same time Ste20p
translocates from cytoplasm into nucleus, where S10 is phosphory-
lated, and induces chromatin condensation. Recently, Buttner et al.
[27] showed that H2B was co-puriﬁed with yeast EndoG homologue
Nuc1p, and the nonphosphorylable point mutation of histone H2B
(H2BS10A) can rescue the effect of Nuc1p-mediated apoptosis upon
0.4 mM H2O2 treatment. In addition, H2B was reported to be able to
bind to an amphibian-derived antimicrobial peptide Dermaseptin S3
(1-16) speciﬁcally, which was shown to kill yeast by a caspase-
independent way [68], but the speciﬁc role of H2B in this process
remains unknown.
5. Crosstalk between caspase-independent pathways and the
caspase cascade
Although it has been well established that there are caspase-
dependent and -independent pathways, it is necessary to point out
that crosstalk exists between these two main pathways in both
mammalian and yeast cells. On one side, multiple apoptotic
pathways can be adopted by a single agent in inducing cellapoptosis. For example, yeast metacaspase Yca1p plays an important
role in Mn- but not Cu-induced process [28]. Mn-induced apoptosis
appears to be affected by multiple known apoptosis components,
but not cyclophilin D and ROS, in both caspase-dependent and
-independent pathways, whereas Cu-induced apoptosis largely relies
on ROS and cyclophilin D. Elimination of one of several apoptosis
components can reduce, but far from eradicate, Mn-induced
apoptotic death. These results demonstrated that contrasting path-
ways are adopted by Cu and Mn in inducing apoptosis, and a single
agent can induce both caspase-dependent and -independent path-
ways. Therefore, various apoptotic pathways can contribute simul-
taneously to a cell's death, and their individual contributions depend
on the speciﬁc apoptosis-inducing stimulus and perhaps even the
cell type [9].
On the other side, evidence is accumulating that there is some
interaction between caspase-dependent and -independent apoptosis
pathways. One study showed that when caspase activation occurs
early during apoptosis, the release of AIF is secondary to activation of
caspase-8 [108]. Conversely, AIF can trigger the release of cyto-
chrome c from isolated mitochondria in vitro [65]. However, while in
several paradigms of cell death induction, AIF is released from
mitochondria before cytochrome c [65,109,110], in other examples of
cell death, it has been reported that mitochondria release AIF well
after cytochrome c [111]. The knockdown of AIF causes a reduction of
developmental cell death in C. elegans but only in animals with
attenuated caspase activation [83]. Intriguingly, some results suggest
that caspases seem to have some role on the translocation of EndoG
and AIF from mitochondria to cytosol through an unknown
mechanism regulated by the proapoptotic members of the Bcl-2
family Bax and Bak [63]. In yeast, treatment of wild-type cells
overexpressing Aif1p with 0.4 mM H2O2 killed 90% of these cells; in
contrast, only 30% of cells were killed when the YCA1 gene had been
deleted from these cells. This suggests that apoptosis potentiated by
overexpression of Aif1p is signiﬁcantly, but not entirely, caspase-
dependent. Consistently, in an in vivo caspase assay, yeast cells
overexpressing Aif1p and treated with 0.4 mM H2O2 displayed an
elevated caspase activity in wild-type background that is attenuated
in the yca1Δ strain [69].
Finally, it appears that some components participate in both
caspase-dependent and -independent apoptotic pathways. Yeast
potential component of permeability transition pore AAC proteins
has been demonstrated to play an important role in EndoG-
mediated apoptosis pathway, which is caspase-independent, and is
also involved in Yca1p-facilitated cell killing as Yca1p-mediated
death is reduced by 70% upon deletion of adenine nucleotide
transporter isoforms [27]. ROS are generated in H2O2-induced
caspase-dependent yeast apoptosis, and meanwhile, ROS were also
detected in Cu-induced Yca1p-independent yeast apoptosis [28].
These data suggest that caspase-dependent and -independent
apoptosis may indeed share some important common components,
and likely intertwine more closely than people originally thought.
6. Conclusions and perspectives
Yeast has been demonstrated to be an excellent model for
investigation of various essential cellular processes, and then helps
to reveal the evolutionary conserved mechanism in more compli-
cated metazoans. In the past ten years or so, yeast apoptosis has
been ﬁrmly established. Almost all elements involved in caspase-
independent apoptosis such as AIF, AMID, EndoG, MPTP as well as
H2B, were shown to be conserved from mammalian to yeast cells.
This series of studies suggest an evolutionary conserved nature for
the cell death processes of metazoans and other eukaryotes and
provide a chance to ask how caspase-independent apoptosis
originated. It is now clear that mitochondria are the integrative
center for both caspase-dependent and -independent apoptosis
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[52]). Recently, it is becoming known that multiple signaling
pathways exist regulating yeast cell death, but hierarchy details of
each pathway and its relative contribution to a particular type of cell
death, and the interaction among different pathways needs to be
further elucidated. The excellent genetic and biochemical yeast
model may provide a good chance for us to answer questions like:
What's the relationship between different caspase-independent
elements? What's the relationship between caspase-dependent and
-independent apoptotic pathways? What's the relationship between
apoptosis and other kind of unwell- or well-studied cell death such
as necrosis and autophagy? In the past, yeast apoptosis study has
largely played a catching-up role in the broad area of apoptosis
research, and the next decade will likely witness a blooming in this
ﬁeld and its leap to the forefront of apoptotic research.
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